Steven B. Ketchum - Feb 1, 2024 Form 4 Insider Report for AMARIN CORP PLC\UK (AMRN)

Role
Chief Scientific Officer
Signature
/s/ Tom Reilly, by power of attorney
Stock symbol
AMRN
Transactions as of
Feb 1, 2024
Transactions value $
$0
Form type
4
Date filed
2/9/2024, 04:30 PM
Previous filing
Feb 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRN Restricted Stock Unit Award $0 +116K $0.00 116K Feb 1, 2024 Ordinary Shares 116K $0.00 Direct F1, F2, F3, F4
transaction AMRN Stock Option (right to buy) Award $0 +418K $0.00 418K Feb 1, 2024 Ordinary Shares 418K $1.21 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.
F2 On February 1, 2024, the Reporting Person was granted 116,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2025, January 31, 2026 and January 31, 2027.
F3 Not applicable
F4 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F5 On February 1, 2024, the Reporting Person was granted an option to purchase 418,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable over three years, with 33% to vest on the first anniversary of the grant date and the balance to vest ratably over the subsequent 12 calendar quarters on the last day of each April, July, October and January.